|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ICI 6-K filed Mar 21, 2007. Share-based payments The Company has applied the requirements of FRS 20 Share-based Payment and has elected not to adopt the exemption to apply FRS 20 only to awards made after 7 November 2002, instead a full retrospective approach has been followed on all grants not fully vested at the date of adoption to maintain consistency across reporting periods. The Company issues equity settled share-based payments to certain employees. Equity settled share-based payments are measured at fair value at grant date. Fair value is measured using the Black-Scholes model, taking into account the terms and conditions upon which the instruments were granted, excluding the impact of any non-market vesting conditions. The total amount to be expensed over the vesting period is determined by reference to the fair value of the equity instruments granted and the number of equity instruments which eventually vest. At each balance sheet date, the Company revises its estimates in respect of non market conditions of the number of equity instruments that are expected to vest. It recognises the impact of the revision of original estimates, if any, in the income statement, and a corresponding adjustment to equity over the remaining vesting period.
Back to Contents
This excerpt taken from the ICI 20-F filed Mar 31, 2006. Share-based
payments
The Group has applied the requirements of IFRS 2 Share-based Payment and has elected not to adopt the exemption to apply IFRS 2 only to awards made after 7 November 2002. Instead a full retrospective approach has been followed on all grants not fully vested at the date of transition to maintain consistency across reporting periods. The fair value of these grants in prior periods has been disclosed previously as part of the ongoing US GAAP disclosure requirements. The Group issues equity settled share-based payments to certain employees. Equity settled share-based payments are measured at fair value at grant date. Fair value is measured using the Black-Scholes model, taking into account the terms and conditions upon which the instruments were granted, excluding the impact of any non-market vesting conditions. The total amount to be expensed over the vesting period is determined by reference to the fair value of the equity instruments granted and the number of equity instruments which eventually vest. At each balance sheet date, the Group revises its estimates of the number of equity instruments that are expected to vest. It recognises the impact of the revision of original estimates, if any, in the income statement, and a corresponding adjustment to equity. Financial
assets Financial
derivatives Financial
derivatives IFRS (2005) The accounting for the Groups various hedging activities is detailed below: Transaction
exposure hedging Forecast
cash flow hedging For effective hedges that include a purchase of a forecast non-monetary item, the gain or loss on the derivative, at the end of the hedge relationship, is capitalised into the carrying value of that non-monetary item. Interest
rate hedging Net
investment hedging (currency hedging) Commodity
hedging Discontinuance
of hedge accounting Fair
value hedges Cash
flow hedges Fair
values
This excerpt taken from the ICI 6-K filed Mar 14, 2006. Share-based
payments
The Group has applied the requirements of IFRS 2 Share-based Payment and has elected not to adopt the exemption to apply IFRS 2 only to awards made after 7 November 2002. Instead a full retrospective approach has been followed on all grants not fully vested at the date of transition to maintain consistency across reporting periods. The fair value of these grants in prior periods has been disclosed previously as part of the ongoing US GAAP disclosure requirements. The Group issues equity settled share-based payments to certain employees. Equity settled share-based payments are measured at fair value at grant date. Fair value is measured using the Black-Scholes model, taking into account the terms and conditions upon which the instruments were granted, excluding the impact of any non-market vesting conditions. The total amount to be expensed over the vesting period is determined by reference to the fair value of the equity instruments granted and the number of equity instruments which eventually vest. At each balance sheet date, the Group revises its estimates of the number of equity instruments that are expected to vest. It recognises the impact of the revision of original estimates, if any, in the income statement, and a corresponding adjustment to equity. Financial
assets Financial
derivatives Financial
derivatives IFRS (2005) The accounting for the Groups various hedging activities is detailed below: Transaction
exposure hedging Forecast
cash flow hedging For effective hedges that include a purchase of a forecast non-monetary item, the gain or loss on the derivative, at the end of the hedge relationship, is capitalised into the carrying value of that non-monetary item. Interest
rate hedging Net
investment hedging (currency hedging) Commodity
hedging Discontinuance
of hedge accounting Fair
value hedges Cash
flow hedges Fair
values
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for ICI: |
| |||||||